Core Laboratories N.V. (CLB)

Core Laboratories N.V. beat consensus on adjusted EPS but revenue came in below estimates in the second fiscal quarter of 2026, reported July 29, based on preliminary results. Adjusted EPS of $0.11 topped the $0.08 estimate by 37.5%, though it was down 42.1% from $0.19 a year ago. Revenue fell 4.3% to about $124.6 million, versus about $130.2 million a year earlier, and missed the $126.3 million consensus by 1.3%. Net income was about $6.0 million, down 44.0% from $10.6 million a year ago, while operating income came to about $9.2 million. The company generated operating cash flow of about $7.8 million, repurchased about $2.7 million of stock, and paid about $460,000 in dividends. For the next period, consensus calls for EPS of $0.18 on revenue of $131.7 million.